eyenovia-logo 3

smart. precise. brilliant.

Eyenovia is a clinical stage, ophthalmic biopharmaceutical company transforming the delivery of therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye disease and many others. Eyenovia’s breakthrough piezo-dispersion and microdosing technology enable a portfolio of first-in-class, next-generation, micro-therapeutics for the eye designed to reduce ocular and systemic toxicity and improve the risk-benefit profile of both new and existing therapeutics.
At Eyenovia, we believe that when it comes to your eyes, smaller is better.

Microdrops: smaller is better!

Eyenovia is leading the charge in how eye care is delivered with its microtherapeutic technology. Eyenovia’s microdrops and high-precision microdosing are designed for more efficient and gentler treatments for the eye with the delivery of 80% less unnecessary drug and preservatives.

Eyenovia: Changing the 100-year old
eyedropper paradigm. Microdrops reduce conventional
overdosing by more than 80%!

Pixel-sharp precision for your eyes

Eyenovia is bringing ocular drug delivery into focus. Our proprietary solution uses piezo-print electronics and microfluidics to generate tiny droplets for high-precision delivery of eye therapies. Applying high-resolution inkjet technology towards the development of micro-therapeutics for the eye, Eyenovia can achieve gentle and precise micro-dosing at 6-8 µL volumes– a dosing far less than the traditional eye drops which overdose the eye with 30-50 µL and often lead to adverse side effects such as redness, irritation and pain.

Eyenovia: High precision targeted
microdroplet therapy …precEYEsely.

    Dry Eye
    Eye Allergy
    Pupil Dilation

    Beat the Blink

    Don’t wait for the drop to fall. Fast piezo-print delivery ensures microdrops gently coat the ocular surface at the speed of your blink, avoiding inconveniences such as overflow down the cheek and into the nose.

    Beat the blink! Eyenovia microdrops are delivered
    within 80 milliseconds…Faster than the blink reflex!

    Smart technology: be smart… eye-smart!

    Eyenovia’s intelligent electronic system is one of the first smart technologies to enter FDA clinical trials for ophthalmic use. Smart sensors and mobile cloud connectivity can help patients and physicians stay on top of treatment plans.

    “Smart eye care...means better eye care! Dynamic, real time monitoring and compliance data for you and your doctor!

    Watch a brief video about our technology


    What is the average volume of your tear film?

    6-8 µL

    The average volume of tear film is 6-8 µL

    How much medication volume
    can the eye hold?


    The eye can hold 6-8 µL of medication volume.

    How much volume is in a conventional eyedropper?

    30-50 µL

    Conventional eye droppers contain 30-50 µL of volume.


    Eyenovia’s development pipeline includes three late stage NDA-enabling programs in key ophthalmic indications

    See more information about our products

    Contact us for more information

    Contact us today to learn more about how our microdosing technology is poised to transform the standard of care in ophthalmic therapeutic delivery.

    295 Madison Avenue, Suite 2400 NY, NY 10017   [email protected]

    Safe Harbor                   Terms of Use            Privacy Policy